SOD1 and amyotrophic lateral sclerosis: In addition, as shown by a pre-specified integration of data from VALOR and its ongoing open-label extension (OLE) study, initiation of tofersen in the early disease stages reduces the deterioration of motor function, respiratory function, muscle strength, and quality of life in people with SOD1-ALS [68].